Viatris Q3 net loss more than doubles to $325.3 million year over year
- Viatris’ third-quarter 2026 GAAP net loss more than doubled year over year to $325.3 million.
- Total revenues fell to $3.75 billion, while GAAP operating cash flow climbed 21% year over year to $899.4 million.
- Supply constraints reduced quarterly total revenues by approximately $100 million, with a similar impact expected in the fourth quarter.
- The planned $1.65 billion acquisition of Pacira BioSciences is expected to close by the end of November 2026.
- For 2026, the total revenues guidance midpoint rose to $14.8 billion, excluding any contribution from Pacira.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viatris Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611050659PR_NEWS_USPR_____NE89310) on November 05, 2026, and is solely responsible for the information contained therein.